Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006–2015): a need for evidence-based policy

• Main Authors: Keim-Malpass J, Mitchell EM, DeGuzman PB, Stoler MH, Kennedy C
• Format: Article
• Language: English
• Published: Dove Medical Press 2017-03-01
• Series: Risk Management and Healthcare Policy
• Subjects: legislation; HPV vaccine; adolescent
• Online Access: https://www.dovepress.com/legislative-activity-related-to-the-human-papillomavirus-hpv-vaccine-i-peer-reviewed-article-RMHP

Jessica Keim-Malpass,1,2 Emma M Mitchell,1 Pamela B DeGuzman,1 Mark H Stoler,3 Christine Kennedy,1,2 1School of Nursing, 2Department of Pediatrics, 3Department of Pathology, School of Medicine, University of Virginia, Charlottesville, VA, USA Abstract: State-based policies to mandate HPV vaccination are politically challenging and have received broad criticisms. There is a critical need to understand the legislative activities that underpin subsequent policy implementation. The objective of this policy analysis was to analyze state legislation that focused on HPV vaccination from 2006–2015. A content analysis was conducted among primary sources of legislative data from HPV vaccine-related bills, including using the National Conference of State Legislatures as a search-source. Findings reveal that much of the legislative activity occurred early after the HPV vaccination was introduced, and focused on increased information for parents, public financing, awareness campaigns, etc. Far fewer states focused on voluntary or mandatory vaccination. Understanding the barriers to achieving mandatory vaccination policy and implementation of such policies for HPV vaccines remains a public health priority. Keywords: HPV vaccine, adolescent, policy, legislation